UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

 

 

Filed by the Registrant  ☒

Filed by a Party other than the Registrant  ☐

Check the appropriate box:

 

Preliminary Proxy Statement

 

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

 

Definitive Proxy Statement

 

Definitive Additional Materials

 

Soliciting Material Pursuant to §240.14a-12

PARATEK PHARMACEUTICALS, INC.

(Name of Registrant as Specified in its Charter)

(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)

Payment of Filing Fee (Check all boxes that apply):

 

No fee required

 

Fee paid previously with preliminary materials

 

Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

 

 

 


This Schedule 14A filing consists of communications from Paratek Pharmaceuticals, Inc., a Delaware corporation (the “Company”), to the Company’s stockholders relating to the Agreement and Plan of Merger, dated June 6, 2023, by and among the Company, Resistance Acquisition, Inc., a Delaware corporation (“Parent”) and Resistance Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (the “Merger Agreement”).

The following communication was first mailed to stockholders from the Company on or about September 12, 2023:


LOGO

FOURTH REMINDER - TAKE ACTION AND PROTECT YOUR INVESTMENT PARATEK PHARMACEUTICALS IF THE TRANSACTION IS NOT APPROVED YOUR INVESTMENT IN PARATEK IS AT RISK As you may know, Paratek Pharmaceuticals, Inc. (“Paratek”) previously announced a definitive agreement to be acquired by Gurnet Point Capital (“Gurnet Point”) and Novo Holdings A/S (“Novo Holdings”). The consequences of failing to approve the transaction, and leaving Paratek as a standalone company, will create near term liquidity needs and would likely result in substantial dilution of ALL stockholders or risk of bankruptcy. Join other Paratek stockholders in voting FOR the transaction. If you do not vote, it has the same effect as voting against the transaction. Time is running out - Vote your shares online today to ensure they are received in time. THE DEADLINE FOR YOUR ONLINE VOTE TO BE RECEIVED IS 11:59 PM ET ON SEPTEMBER 17, 2023. If the transaction is approved, stockholders will receive both an immediate cash payment of $2.15 per share plus a contingent value right of $0.85 per share payable upon the achievement of a net sales threshold for NUZYRA, representing an aggregate potential total value of $3.00 per share. The upfront cash payment at the closing of the transaction represents a premium of 41% over the closing price of our common stock as of May 31, 2023’. Every vote is important, no matter how many shares you own. Please vote your proxy today “FOR” the transaction. For Assistance in Voting Your Proxy, Please Contact Our Proxy Solicitor Morrow Sodali LLC Today at +1 (800) 662-5200 (toll-free in North America) +1 (203) 658-9400 (collect outside of North America) PRTK@info.morrowsodali.com ‘The last full trading day prior to market speculation regarding a potential sale of Paratek.


LOGO

FOURTH REMINDER—TAKE ACTION AND PROTECT YOUR INVESTMENT Cautionary Statement Regarding Forward-Looking Statements TKLV TKLV FRPPXQLFDWLRQ FRPPXQLFDWLRQ LQFOXGHV LQFOXGHV IRUZDUG_ORRNLQJ IRUZDUG_ORRNLQJ VWDWHPHQWV VWDWHPHQWV WKDW WKDW DUH DUH VXEMHFW VXEMHFW WR WR ULVNV_ ULVNV_ XQFHUWDLQWLHV XQFHUWDLQWLHV DQG DQG RWKHU RWKHU IDFWRUV IDFWRUV WKDW WKDW FRXOG FRXOG FDXVH FDXVH DFWXDO DFWXDO UHVXOWV WR GLIIHU PDWHULDOO IURP WKRVH LPSOLHG E WKH IRUZDUG_ORRNLQJ VWDWHPHQWV_ AOO VWDWHPHQWV RWKHU WKDQ VWDWHPHQWV RI KLVWRULFDO IDFW DUH VWDWHPHQWV WKDW FRXOG EH GHHPHG IRUZDUG_ORRNLQJ VWDWHPHQWV_ LQFOXGLQJ DOO VWDWHPHQWV UHJDUGLQJ WKH LQWHQW_ EHOLHI RU FXUUHQW H[SHFWDWLRQ RI PDUDWHN PKDUPDFHXWLFDOV_ IQF_ _WKH łCRPSDQ´_ DQG PHPEHUV RI LWV VHQLRU PDQDJHPHQW WHDP DQG FDQ WSLFDOO EH LGHQWLILHG E ZRUGV VXFK DV ³EHOLHYH_´ ³H[SHFW_´ ³HVWLPDWH_´ ³SUHGLFW_´ ³WDUJHW_´ ³SRWHQWLDO_´ łOLNHO_´ ³FRQWLQXH_´ ³RQJRLQJ_´ ³FRXOG_´ ³VKRXOG_´ ³LQWHQG_´ łPD_´ ³PLJKW_´ ³SODQ_´ ³VHHN_´ ³DQWLFLSDWH_´ ³SURMHFW´ DQG VLPLODU H[SUHVVLRQV_ DV ZHOO DV YDULDWLRQV RU QHJDWLYHV RI WKHVH ZRUGV_ )RUZDUG_ORRNLQJ VWDWHPHQWV LQFOXGH_ ZLWKRXW OLPLWDWLRQ_ VWDWHPHQWV UHJDUGLQJ WKH SURSRVHG WUDQVDFWLRQ_ VLPLODU WUDQVDFWLRQV_ SURVSHFWLYH SHUIRUPDQFH_ IXWXUH SODQV_ HYHQWV_ H[SHFWDWLRQV_ SHUIRUPDQFH_ REMHFWLYHV DQG RSSRUWXQLWLHV DQG WKH RXWORRN IRU WKH CRPSDQ¶V EXVLQHVV_ WKH FRPPHUFLDO VXFFHVV RI WKH CRPSDQ¶V SURGXFWV_ WKH WLPLQJ RI DQG UHFHLSW RI ILOLQJV DQG DSSURYDOV UHODWLQJ WR WKH SURSRVHG WUDQVDFWLRQ_ WKH H[SHFWHG WLPLQJ RI WKH FRPSOHWLRQ RI WKH SURSRVHG WUDQVDFWLRQ_ WKH DELOLW WR FRPSOHWH WKH SURSRVHG WUDQVDFWLRQ FRQVLGHULQJ WKH YDULRXV FORVLQJ FRQGLWLRQV_ DQG WKH DFFXUDF DFFXUDF RI RI DQ DQ DVVXPSWLRQV DVVXPSWLRQV XQGHUOLQJ XQGHUOLQJ DQ DQ RI RI WKH WKH IRUHJRLQJ_ IRUHJRLQJ_ IQYHVWRUV IQYHVWRUV DUH DUH FDXWLRQHG FDXWLRQHG WKDW WKDW DQ DQ VXFK VXFK IRUZDUG_ORRNLQJ IRUZDUG_ORRNLQJ VWDWHPHQWV VWDWHPHQWV DUH DUH QRW QRW JXDUDQWHHV RI IXWXUH SHUIRUPDQFH DQG LQYROYH ULVNV DQG XQFHUWDLQWLHV DQG DUH FDXWLRQHG QRW WR SODFH XQGXH UHOLDQFH RQ WKHVH IRUZDUG_ORRNLQJ VWDWHPHQWV_ AFWXDO UHVXOWV PD GLIIHU PDWHULDOO IURP WKRVH FXUUHQWO DQWLFLSDWHG GXH WR D QXPEHU RI ULVNV DQG XQFHUWDLQWLHV_ RLVNV DQG XQFHUWDLQWLHV WKDW FRXOG FDXVH WKH DFWXDO UHVXOWV WR GLIIHU IURP H[SHFWDWLRQV FRQWHPSODWHG E IRUZDUG_ORRNLQJ VWDWHPHQWV LQFOXGH_ XQFHUWDLQWLHV DV WR WKH WLPLQJ RI WKH PHUJHU_ XQFHUWDLQWLHV DV WR KRZ PDQ RI WKH CRPSDQ¶V VWRFNKROGHUV ZLOO YRWH WKHLU VWRFN LQ IDYRU RI WKH SURSRVHG WUDQVDFWLRQ_ WUDQVDFWLRQ_ WKH WKH RFFXUUHQFH RFFXUUHQFH RI RI DQ DQ HYHQW_ HYHQW_ FKDQJH FKDQJH RU RU RWKHU RWKHU FLUFXPVWDQFH FLUFXPVWDQFH WKDW WKDW FRXOG FRXOG JLYH JLYH ULVH ULVH WR WR WKH WKH WHUPLQDWLRQ WHUPLQDWLRQ RI RI WKH WKH AJUHHPHQW AJUHHPHQW DQG DQG PODQ PODQ RI RI MHUJHU_ GDWHG DV RI -XQH __ _____ DPRQJ WKH CRPSDQ_ RHVLVWDQFH MHUJHU SXE_ IQF_ _³MHUJHU SXE´_ DQG RHVLVWDQFH AFTXLVLWLRQ_ IQF_ _WKH ³MHUJHU AJUHHPHQW´__ LQFOXGLQJ FLUFXPVWDQFHV UHTXLULQJ D SDUW WR SD WKH RWKHU SDUW D WHUPLQDWLRQ IHH SXUVXDQW WR WKH MHUJHU AJUHHPHQW_ WKH DELOLW RI WKH SDUWLHV WR FRQVXPPDWH WKH SURSRVHG WUDQVDFWLRQ RQ D WLPHO EDVLV RU DW DOO_ WKH VDWLVIDFWLRQ RI WKH FRQGLWLRQV SUHFHGHQW WR WKH FRQVXPPDWLRQ RI WKH SURSRVHG WUDQVDFWLRQ_ LQFOXGLQJ WKH DELOLW WR VHFXUH VWRFNKROGHU DSSURYDO RQ WKH WHUPV H[SHFWHG_ DW DOO RU LQ D WLPHO PDQQHU_ WKH HIIHFWV RI WKH WUDQVDFWLRQ _RU WKH DQQRXQFHPHQW RU SHQGHQF WKHUHRI_ RQ UHODWLRQVKLSV ZLWK DVVRFLDWHV_ FXVWRPHUV_ PDQXIDFWXUHUV_ VXSSOLHUV_ HPSORHHV _LQFOXGLQJ WKH ULVNV UHODWLQJ WR WKH DELOLW WR UHWDLQ RU KLUH NH SHUVRQQHO__ RWKHU EXVLQHVV SDUWQHUV RU JRYHUQPHQWDO HQWLWLHV_ WUDQVDFWLRQ FRVWV_ WKH ULVN WKDW WKH PHUJHU ZLOO GLYHUW PDQDJHPHQW¶V DWWHQWLRQ IURP WKH CRPSDQ¶V RQJRLQJ EXVLQHVV RSHUDWLRQV RU RWKHUZLVH GLVUXSW WKH CRPSDQ¶V RQJRLQJ EXVLQHVV RSHUDWLRQV_ FKDQJHV LQ WKH CRPSDQ¶V EXVLQHVVHV GXULQJ WKH SHULRG EHWZHHQ QRZ DQG WKH FORVLQJ_ FHUWDLQ UHVWULFWLRQV GXULQJ WKH SHQGHQF RI WKH SURSRVHG WUDQVDFWLRQ WKDW PD LPSDFW WKH CRPSDQ¶V DELOLW WR SXUVXH FHUWDLQ EXVLQHVV RSSRUWXQLWLHV RU VWUDWHJLF WUDQVDFWLRQV_ ULVNV DVVRFLDWHG ZLWK OLWLJDWLRQ UHODWLQJ WR WKH SURSRVHG WUDQVDFWLRQ_ WKH CRPSDQ¶V DELOLW WR FRQWLQXH DV D JRLQJ FRQFHUQ_ WKH CRPSDQ¶V DELOLW WR PDLQWDLQ RU H[SDQG UHJXODWRU DSSURYDOV RU FRPPHUFLDOL]H WKH CRPSDQ¶V SURGXFWV_ WKH UHVXOWV RI DQ RQJRLQJ RU IXWXUH FOLQLFDO WULDOV PD QRW VDWLVI U_S_ RU QRQ_U_S_ UHJXODWRU DXWKRULWLHV_ WKH UHJXODWRU DSSURYDO SURFHVV LV H[SHQVLYH_ WLPH FRQVXPLQJ DQG XQFHUWDLQ_ WKH CRPSDQ¶V GHSHQGHQFH RQ WKH FRPPHUFLDOL]H VXFFHVV RI 1U=<RA DQG_ WR D OHVVHU H[WHQW_ SE<SARA_ WKH CRPSDQ¶V CRPSDQ¶V GHSHQGHQFH GHSHQGHQFH RQ RQ IXQGLQJ IXQGLQJ IURP IURP %AR’A_ %AR’A_ WKH WKH CRPSDQ¶V CRPSDQ¶V VXEVWDQWLDO VXEVWDQWLDO LQGHEWHGQHVV_ LQGHEWHGQHVV_ ULVN ULVN DVVRFLDWHG DVVRFLDWHG ZLWK ZLWK OLWLJDWLRQ_ OLWLJDWLRQ_ WKH WKH XQFHUWDLQW XQFHUWDLQW DVVRFLDWHG ZLWK WKH FXUUHQW ZRUOGZLGH HFRQRPLF FRQGLWLRQV DQG WKH FRQWLQXLQJ LPSDFW RQ HFRQRPLF DQG ILQDQFLDO FRQGLWLRQV LQ WKH UQLWHG SWDWHV DQG DURXQG WKH ZRUOG_ LQFOXGLQJ DV D UHVXOW RI C29I’____ ULVLQJ LQIODWLRQ_ LQFUHDVLQJ LQWHUHVW UDWHV_ QDWXUDO GLVDVWHUV_ PLOLWDU FRQIOLFWV_ LQFOXGLQJ WKH FRQIOLFW EHWZHHQ RXVVLD DQG UNUDLQH_ WHUURULVW DWWDFNV DQG RWKHU VLPLODU PDWWHUV_ DQG RWKHU ULVNV DQG XQFHUWDLQWLHV GHWDLOHG IURP WLPH WR WLPH LQ GRFXPHQWV ILOHG ZLWK WKH SEC E WKH CRPSDQ_ LQFOXGLQJ FXUUHQW UHSRUWV RQ )RUP __._ TXDUWHUO UHSRUWV RQ )RUP ___4 DQG DQQXDO UHSRUWV RQ )RUP ___._ AOO IRUZDUG_ORRNLQJ VWDWHPHQWV DUH EDVHG RQ LQIRUPDWLRQ FXUUHQWO DYDLODEOH WR WKH CRPSDQ DQG WKH CRPSDQ DVVXPHV QR REOLJDWLRQ WR XSGDWH DQ IRUZDUG_ORRNLQJ VWDWHPHQWV_ ZKHWKHU DV D UHVXOW RI QHZ LQIRUPDWLRQ_ IXWXUH GHYHORSPHQWV RU RWKHUZLVH_ H[FHSW DV PD EH UHTXLUHG E DSSOLFDEOH ODZ_ TKH LQIRUPDWLRQ VHW IRUWK KHUHLQ VSHDNV RQO DV RI WKH GDWH KHUHRI_ Additional Information and Where to Find It TKLV TKLV FRPPXQLFDWLRQ FRPPXQLFDWLRQ PD PD EH EH GHHPHG GHHPHG VROLFLWDWLRQ VROLFLWDWLRQ PDWHULDO PDWHULDO LQ LQ UHVSHFW UHVSHFW RI RI WKH WKH SURSRVHG SURSRVHG DFTXLVLWLRQ DFTXLVLWLRQ RI RI WKH WKH CRPSDQ CRPSDQ E E MHUJHU MHUJHU SXE_ SXE_ TKLV TKLV FRPPXQLFDWLRQ FRPPXQLFDWLRQ GRHV GRHV QRW QRW FRQVWLWXWH FRQVWLWXWH D D VROLFLWDWLRQ VROLFLWDWLRQ RI RI DQ DQ YRWH YRWH RU RU DSSURYDO_ DSSURYDO_ IQ IQ FRQQHFWLRQ FRQQHFWLRQ ZLWK ZLWK WKH WKH SURSRVHG SURSRVHG WUDQVDFWLRQ_ WUDQVDFWLRQ_ WKH WKH CRPSDQ CRPSDQ KDV KDV ILOHG ILOHG D GHILQLWLYH SUR[ VWDWHPHQW ZLWK WKH U_S_ SHFXULWLHV DQG E[FKDQJH CRPPLVVLRQ _WKH ³SEC´_ RQ AXJXVW __ ____ _WKH łPUR[ SWDWHPHQW´__ TKH CRPSDQ PDLOHG RU RWKHUZLVH SURYLGHG WKH GHILQLWLYH SUR[ VWDWHPHQW WR LWV VWRFNKROGHUV LQ FRQQHFWLRQ ZLWK WKH SURSRVHG WUDQVDFWLRQ RQ RU DERXW AXJXVW __ _____ TKH CRPSDQ DQG DIILOLDWHV RI WKH CRPSDQ KDYH MRLQWO ILOHG D WUDQVDFWLRQ VWDWHPHQW RQ SFKHGXOH __H__ _WKH ³SFKHGXOH __H__´__ TKH CRPSDQ PD DOVR ILOH RWKHU GRFXPHQWV ZLWK WKH SEC UHJDUGLQJ WKH SURSRVHG WUDQVDFWLRQ_ TKLV GRFXPHQW LV QRW D VXEVWLWXWH IRU WKH PUR[ SWDWHPHQW RU DQ RWKHU GRFXPHQW WKDW PD EH ILOHG E WKH CRPSDQ ZLWK WKH SEC_ %E)2RE %E)2RE MA MA. .I1* I1* A1< A1< 92TI1* 92TI1* ‘ECISI21_ ‘ECISI21_ THE THE C2MPA1<¶S C2MPA1<¶S ST2C ST2C. .H2L’ERS H2L’ERS ARE ARE UR*E’ UR*E’ T2 T2 REA’ REA’ THE THE PR2;< PR2;< STATEME1T STATEME1T A1’ A1’ THE THE SCHE’ULE SCHE’ULE __E__ __E__ I1 I1 THEIR THEIR E1TIRET< E1TIRET< A1’ A1’ A1< A1< 2THER 2THER ‘2CUME1TS ‘2CUME1TS )ILE’ )ILE’ %< %< THE THE C2MPA1< C2MPA1< :ITH :ITH THE THE SEC SEC I1 I1 C211ECTI21 C211ECTI21 :ITH THE PR2P2SE’ TRA1SACTI21 2R I1C2RP2RATE’ %< RE)ERE1CE THEREI1 %E)2RE MA.I1* A1< 92TI1* 2R I19ESTME1T ‘ECISI21 :ITH RESPECT T2 THE PR2P2SE’ TRA1SACTI21 %ECAUSE THE< C21TAI1 IMP2RTA1T I1)2RMATI21 A%2UT THE PR2P2SE’ TRA1SACTI21 A1’ THE PARTIES T2 THE PR2P2SE’ TRA1SACTI21_ AQ AQ YRWH YRWH LQ LQ UHVSHFW UHVSHFW RI RI UHVROXWLRQV UHVROXWLRQV WR WR EH EH SURSRVHG SURSRVHG DW DW D D VWRFNKROGHU VWRFNKROGHU PHHWLQJ PHHWLQJ RI RI WKH WKH CRPSDQ CRPSDQ WR WR DSSURYH DSSURYH WKH WKH SURSRVHG SURSRVHG WUDQVDFWLRQ WUDQVDFWLRQ RU RU UHODWHG UHODWHG PDWWHUV_ RU RWKHU UHVSRQVHV LQ UHODWLRQ WR WKH SURSRVHG WUDQVDFWLRQ_ VKRXOG EH PDGH RQO RQ WKH EDVLV RI WKH LQIRUPDWLRQ FRQWDLQHG LQ WKH PUR[ SWDWHPHQW_ SWRFNKROGHUV PD REWDLQ D IUHH FRS RI WKH PUR[ SWDWHPHQW_ WKH SFKHGXOH __H__ DQG RWKHU GRFXPHQWV WKH CRPSDQ ILOHV ZLWK WKH SEC _ZKHQ DYDLODEOH_ WKURXJK WKH ZHEVLWH PDLQWDLQHG E WKH SEC DW ZZZ_VHF_JRY_ TKH CRPSDQ PDNHV DYDLODEOH IUHH RI FKDUJH RQ LWV LQYHVWRU UHODWLRQV ZHEVLWH DW ZZZ_SDUDWHNSKDUPD_FRP_LQYHVWRU_UHODWLRQV FRSLHV RI PDWHULDOV LW ILOHV ZLWK_ RU IXUQLVKHV WR_ WKH SEC_ TKH TKH SURSRVHG SURSRVHG WUDQVDFWLRQ WUDQVDFWLRQ ZLOO ZLOO EH EH LPSOHPHQWHG LPSOHPHQWHG VROHO VROHO SXUVXDQW SXUVXDQW WR WR WKH WKH AJUHHPHQW AJUHHPHQW DQG DQG PODQ PODQ RI RI MHUJHU_ MHUJHU_ GDWHG GDWHG DV DV RI RI—-XQH XQH __ __ _____ _____ DPRQJ DPRQJ WKH WKH CRPSDQ_ MHUJHU SXE DQG RHVLVWDQFH AFTXLVLWLRQ_ IQF__ ZKLFK FRQWDLQV WKH IXOO WHUPV DQG FRQGLWLRQV RI WKH SURSRVHG WUDQVDFWLRQ_ PHARMACEUTICALS


Paratek Pharmaceuticals (NASDAQ:PRTK)
Historical Stock Chart
Von Mai 2024 bis Jun 2024 Click Here for more Paratek Pharmaceuticals Charts.
Paratek Pharmaceuticals (NASDAQ:PRTK)
Historical Stock Chart
Von Jun 2023 bis Jun 2024 Click Here for more Paratek Pharmaceuticals Charts.